LAURUS LABS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 419 INR | -2.08% |
|
-6.88% | -2.62% |
| 30/05 | Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab | MT |
| 15/05 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 2.77B | ||||||
| 734B | ||||||
| 591B | ||||||
| 350B | ||||||
| 315B | ||||||
| 276B |
